2021 Update in Addiction Medicine - Enduring Package

Monday, December 6, 2021, 12:00 AM - Friday, December 6, 2024, 12:00 AM, osu.cloud-cme.com


American Academy of Family Physicians Elective Credit(s) (4.00 hours), AOA Category 1-B (4.00 hours), General Attendance (4.00 hours)

The presentations from our original 2021 Update in Addiction Medicine conference are now available as an enduring material package of 4 AOA Category 1B credits!

To receive CME credit for this package, you will need to review all presentations, answer the required attestation, and complete the overall package evaluation.  Upon completion of the evaluation, your credit certificate and transcript will immediately be available.

The presentations in this package include:

• Treatment of Methamphetamine Use Disorder-Jason Beaman, DO
• Buprenorphine XR: How It’s Going-Kelly Dunn, MD and Amber Brightmire, LPN
• How Clinical Neuroscience Could Reshape the Future of Addiction Medicine-Hamed Ekhtiari, MD
• Sleep and Addiction-Lowell Robertson, MD

1. Understand the current methamphetamine epidemic.
2. Describe the association between sleep and recovery from use disorders.
3. Understand how opioid use disorder treatment is selected.

AOA Credit
The Oklahoma State University College of Osteopathic Medicine is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Oklahoma State University College of Osteopathic Medicine designates this program for a maximum of 4 AOA Category 1-B credit(s), and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

AAFP Credit
Activities approved by the American Osteopathic Association are acceptable as AAFP Elective Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MATE Act - DEA
The 2021 Update in Addiction Medicine - Enduring Package meets the new Medication Access and Training Expansion (MATE) Act requirements from the Drug Enforcement Administration (DEA) for training on substance use disorders. Providers planning to receive or renew their DEA registration can earn 4 hour towards their 8 hour MATE requirement by participating. 

Cancellation Policy

No refunds will be granted for online CME courses, except in cases where the content may be inaccessible to the user, and the inaccessibility cannot be resolved by Tech Support.

Questions

For questions about accessing course content or general inquiries, please contact our staff at [email protected]

Program Attendee Notice

Concerns about the program’s compliance with the AOA Uniform Guidelines, please contact:

Ashley Groom, M.S., Director of Continuing Medical Education

For any unresolved issues regarding compliance with the AOA Uniform Guidelines, you may contact the AOA:
American Osteopathic Association:
Council on Continuing Medical Education
142 E. Ontario St., Chicago, IL 60611
(800) 621-1773

Course Faculty

Jason Beaman, DO

Kelly Dunn, MD

Amber Brightmire, LPN

Hamed Ekhtiari, MD

Lowell Robertson, MD

 

Relevant Disclosures

At the time the presentations were recorded, no content controllers had any relevant financial interests to disclose.

The Oklahoma State University Center for Health Sciences, College of Osteopathic Medicine, adheres to the AOA Guidelines for CME sponsors and the ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Oklahoma State University Continuing Medical Education adheres to the American Osteopathic Associations Guideline for CME Sponsors and ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.